Agilent Technologies (NYSE:A) Releases FY 2026 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 6.180-6.210 for the period, compared to the consensus earnings per share estimate of 6.060. The company issued revenue guidance of $7.5 billion-$7.5 billion, compared to the consensus revenue estimate of $7.4 billion. Agilent Technologies also updated its Q4 2026 guidance to 1.710-1.740 EPS.

Agilent Technologies Stock Up 0.3%

A stock opened at $155.16 on Thursday. The company has a market capitalization of $43.82 billion, a P/E ratio of 31.16, a price-to-earnings-growth ratio of 2.73 and a beta of 1.25. Agilent Technologies has a 12 month low of $108.35 and a 12 month high of $160.51. The firm’s fifty day simple moving average is $139.16 and its 200-day simple moving average is $126.65. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.13. The firm had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm’s revenue was up 8.1% compared to the same quarter last year. During the same quarter last year, the company posted $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, equities research analysts forecast that Agilent Technologies will post 6.05 earnings per share for the current year.

Analysts Set New Price Targets

A has been the subject of several recent analyst reports. Robert W. Baird lifted their price target on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research note on Tuesday, May 26th. Morgan Stanley lifted their price target on shares of Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Royal Bank Of Canada began coverage on shares of Agilent Technologies in a report on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 price target for the company. Wells Fargo & Company reduced their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Thursday, May 28th. Finally, Jefferies Financial Group began coverage on shares of Agilent Technologies in a research report on Thursday, July 9th. They issued a “hold” rating and a $135.00 target price on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $160.24.

Trending Headlines about Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and ahead of the approximately $1.84 billion analyst estimate. Adjusted earnings were $1.62 per share, above the $1.48-$1.49 consensus and up from $1.37 a year earlier. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: Management raised fiscal 2026 adjusted EPS guidance to $6.18-$6.21, above the $6.06 consensus, and set revenue guidance at approximately $7.5 billion, slightly ahead of expectations. Fourth-quarter EPS guidance of $1.71-$1.74 was at or above consensus. Agilent Boosts FY View on Higher 3Q Profit, Revenue
• Positive Sentiment: Profitability and cash generation strengthened. Operating profit rose 23.3% to $444 million, while operating cash flow increased 43.4% to $519 million. The company ended the quarter with approximately $1.8 billion in cash and relatively moderate leverage. Agilent Technologies Stock Rises on Q3 2026 Earnings
• Neutral Sentiment: The earnings beat and guidance increase helped push the stock toward a recent high. However, Agilent already trades near its 52-week high, with a P/E ratio above 31 and a median analyst price target of about $155, suggesting much of the improved outlook may already be reflected in the valuation.

Institutional Trading of Agilent Technologies

A number of hedge funds have recently bought and sold shares of the business. State of Wyoming purchased a new position in Agilent Technologies in the 2nd quarter worth approximately $35,000. Transamerica Financial Advisors LLC grew its position in shares of Agilent Technologies by 180.8% in the fourth quarter. Transamerica Financial Advisors LLC now owns 337 shares of the medical research company’s stock valued at $46,000 after purchasing an additional 217 shares in the last quarter. Johnson Financial Group Inc. acquired a new stake in shares of Agilent Technologies in the third quarter valued at approximately $49,000. DV Equities LLC acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at approximately $54,000. Finally, Itau Unibanco Holding S.A. purchased a new position in Agilent Technologies during the fourth quarter worth approximately $58,000.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.